TDS Famotidine Tablet 20 mg

Adult dose

1. Gastric ulcers, duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding, gastroesophageal reflux disease, Zollinger-Ellison syndrome: 20 mg orally twice a day (after breakfast, after dinner, or before bedtime) or 40 mg orally once daily (at bedtime). Initiate treatment with an injection for upper gastrointestinal bleeding, then switch to oral administration. 2. Acute gastritis and acute exacerbation of chronic gastritis: 10 mg orally twice a day (after breakfast, after dinner, or before bedtime) or 20 mg orally once daily (at bedtime). Dosage should be adjusted according to age and symptoms.

This medication should not be used by individuals who are allergic to this drug's ingredients or similar medications. Additionally, this medication contains lactose, and individuals with a genetic disease that prevents lactose digestion should not take it. Those with a history of drug allergies or impaired kidney function should use this medication with caution, and dosage adjustments may be required. Individuals with heart disease or liver function problems should also take this drug carefully, and elderly patients need to exercise caution. While taking this medication, rare but serious allergic reactions, blood abnormalities, skin reactions, liver dysfunction, muscle damage, heart rhythm abnormalities, and kidney issues may occur, so symptoms should be closely monitored. If any of these side effects are suspected, immediately stop taking the medication and consult a healthcare professional. This medication is absorbed through the mucosa of the mouth, but since it is not directly absorbed there, it must be swallowed with saliva or water. Patients receiving hemodialysis need to be cautious as the combination of this medication and certain phosphate binders may reduce its effectiveness. This medication may interact with others, so it is essential to inform healthcare professionals when taking especially antifungal agents or specific chemotherapy agents. Women who are pregnant or may become pregnant should only take this medication after carefully considering its benefits and risks, and it is recommended that breastfeeding women discontinue nursing. The safety in children has not been adequately established, so caution is advised. In the case of orally disintegrating tablets, they should not be swallowed without water while lying down, but placed on the tongue to dissolve before swallowing. Finally, this drug may mask symptoms of gastric cancer, so it is important to take this medication only after confirming it is not gastric cancer.

Serious side effects

Shock, hypersensitivity (anaphylaxis, dyspnea, generalized flushing, angioedema (facial swelling, pharyngeal swelling, etc.), urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome (mucocutaneous syndrome), Lyell syndrome (toxic epidermal necrolysis), liver dysfunction, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia (including Torsades de Pointes), ventricular fibrillation, altered consciousness, seizures, interstitial pneumonia

Mild side effects

• Rash
• urticaria (erythema)
• facial swelling
• leukopenia
• eosinophilia
• constipation
• diarrhea
• dry mouth
• nausea
• vomiting

Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature of between 1 degree and 30 degrees Celsius.

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle